Metabolon

Let’s meet in Basel!

Join Metabolon at Booth #33 on 13-14 October at Biomarkers, CDx & Precision Medicine Europe and NextGen Omics, Tech & Data.

Discover how metabolomics can help connect biomarker discovery with disease biology and clinical research, and catch these two presentations:

🎤 Oral presentation | Ujjwal Mukund Mahajan
“Prospective Diagnostic Validation of Two Plasma Multi-Metabolite Signatures in an Enrichment Design for Patients with Suspected or at Risk of Pancreatic Cancer”
📅 Wednesday, 14 October | 12:35–13:00
📍 Conference Room 1

📊 Poster presentation | Joe Forster, Metabolon
“Turning an untargeted metabolomics experiment into a ranked, evidence-linked, multiomic, mechanistic hypothesis — a neonatal encephalopathy case study”
📅 13–14 October
📍 Poster Area

Stop by our booth to discuss your research and explore where metabolomics could add value.

At ? Come meet the Metabolon team at booth Q.03.

Diabetes is more than glucose. Metabolomics helps researchers explore the biochemical changes underlying the disease and its complications, connecting genetics, lifestyle, and the microbiome.

Stop by to discuss how these insights could support your research: from risk assessment and patient stratification to understanding disease mechanisms, identifying therapeutic targets, and assessing treatment response.

What diabetes research question are you working to answer? We’d love to hear about it!

What can we learn when we connect the different layers of biology? 🧬

Our new Guide to Multiomics explores what becomes possible when researchers bring together genomomics, transcriptomics, proteomics, and metabolomics.

Through case studies in oncology, neurodegenerative disease, and microbiome research, it shows how Metabolon data adds a view of biochemical activity, helping connect molecular findings to biological function.

The guide also covers integration methods, including machine learning and data harmonization.

Download the guide: https://bit.ly/4Aw468o

Let’s meet in Milan!

Metabolon will be exhibiting at , where we’ll be sharing how comprehensive metabolomics can reveal the biological complexity of diabetes and help researchers:

🔸 Assess risk and stratify patients based on their underlying biology
🔸 Characterize treatment response and understand why outcomes differ
🔸 Uncover disease mechanisms and identify potential therapeutic targets
🔸 Integrate metabolomics with other omics data for a more complete biological picture

📅 September 28–October 2
📍 Milan, Italy
📌 Booth Q.03

Visit our team to discover how high-quality, reproducible metabolomics data can add deeper biological context to your diabetes research.

Only 15 days left to apply for this quarter’s Metabolon Peak Science Grant!

Could metabolomics help unlock the next breakthrough in your research? Each quarter, we select three finalists and award one winning project a fully funded, Metabolon-supported metabolomics study.

The winning researcher receives:

🔬 Study design and statistical power consultation
🧪 Analysis of up to 100 qualified samples
📊 Access to bioinformatics tools and biological interpretation guidance

Researchers in academia and industry across a range of life science disciplines are encouraged to apply.

And the finalists a 10% credit toward a future Metabolon project too!

Applications close September 30, 2026.

Apply today: https://bit.ly/4wP3M2t

📢 Attending the 11th Annual Meeting of Alliance Against Cancer in Naples?

Tomorrow, Dr. Kristi Buzo of IRCC Candiolo Cancer Institute will present research exploring how targeting WEE1 could help overcome acquired resistance to EGFR blockade in colorectal cancer.

The study features Metabolon metabolomics data, demonstrating how comprehensive biochemical profiling can be incorporated into oncology research to investigate the biology underlying treatment resistance and response.

🎤 Leveraging replication stress through WEE1 inhibition to overcome acquired resistance to EGFR blockade in colorectal cancer

📅 September 11
🕝 14:40
📍 Auditorium

If you’re attending , add this presentation to your agenda to see metabolomics in action in colorectal cancer research.

Attending and curious about Metabolon Verus™?

Tomorrow, Heino Heyman, Director of Global Field Metabolomic Sciences at Metabolon, will take the stage to share the story behind Metabolon Verus™ and the data demonstrating its performance across independent laboratories.

📢 One Kit. Multiple Labs. Reproducible Biochemistry. Now in Your Lab.
📅 September 10
🕛 12:00 PM
📍 MANA 2026 | UC Davis

Join Heino to see how a standardized metabolomics workflow can deliver reproducible biochemistry across laboratories, and bring that capability directly into your lab.

Commercial orders for Metabolon Verus™ are now open, with shipping beginning October 1!

Metabolon Verus™ brings a standardized, end-to-end untargeted metabolomics workflow directly into your lab, helping you generate high-quality, reproducible metabolomics data without having to build and optimize a workflow from scratch.

With Metabolon Verus™, labs can:

• Build on 25+ years of Metabolon metabolomics expertise in their own lab
• Generate consistent, high-quality comparable data across sites
• Scale metabolomics more easily
• Access the Integrated Bioinformatics Platform for deeper insights and faster interpretation

And the reproducibility has been put to the test.

A global ring trial across eight independent labs demonstrated 89% metabolite overlap and a 0.91 median correlation with 7-point calibrated quantitative targeted panels, while strongly conserving the underlying biological response.

Combined with our Early Access Program across 10 laboratories in five countries, the results demonstrate what’s possible when metabolomics is designed for reproducibility, scalability, and biological insight from the start.

Bring the power of Metabolon into your lab.
🔗 Order now: https://bit.ly/3UXAxfJ

International availability coming in early 2027.